BlackRock Fund Advisors’s aTyr Pharma ATYR Stock Holding History

BlackRock Fund Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$88K	Sell	2,926 -22,361	-88%	-$917K	﹤0.01%	3645
2016 Q3	$1.13M	Buy	25,287 +111	+0.4%	+$4.8K	﹤0.01%	3221
2016 Q2	$980K	Sell	25,176 -8,001	-24%	-$372K	﹤0.01%	3266
2016 Q1	$1.83M	Buy	33,177 +1,467	+5%	+$112K	﹤0.01%	3102
2015 Q4	$4.36M	Buy	31,710 +20,108	+173%	+$2.86M	﹤0.01%	2905
2015 Q3	$1.67M	Buy	11,602 +249	+2%	+$56.8K	﹤0.01%	3150
2015 Q2	$2.94M	Buy	+11,353	New	+$3.53M	﹤0.01%	3106

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

GHCM

Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

BlackRock Fund Advisors's ATYR Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its aTyr Pharma (ATYR) stake by 88% in Q4 2016, selling an estimated $917K and leaving 2,926 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #3645.

BlackRock Fund Advisors first reported a position in ATYR in Q2 2015 and has held it in 7 quarters since. The position peaked at $4.36M in Q4 2015. 52 funds tracked by Wall St. Rank hold ATYR as of Q4 2016.

BlackRock Fund Advisors held 2,926 shares of aTyr Pharma worth $88K as of Q4 2016.
BlackRock Fund Advisors sold 22,361 aTyr Pharma shares in Q4 2016, an estimated $917K.
aTyr Pharma made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3645 holding.
BlackRock Fund Advisors first reported a position in aTyr Pharma in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's aTyr Pharma position peaked at $4.36M in Q4 2015.
52 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.